Product Code: PM5002
The global multi-omics market size is expected to reach USD 8,696.36 Million by 2032, according to a new study by Polaris Market Research. The report "Multiomics Market Share, Size, Trends, Industry Analysis Report, By Product & Services (Products, and Services); By Type (Single-cell Multi-omics, and Bulk Multi-omics); By Platform; By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The multi-omics market is significantly driven by the increasing investment in advanced 3D multi-omics profiling by the pharmaceutical & biotechnology companies due to its various benefits, such as enhanced drug development and comprehensive understanding. For instance, in November 2023, Stellaromics, a provider of multi-omics technology, raised USD 25 million in series A funding to advance 3D spatial multi-omics profiling.
Integration of Artificial Intelligence (AI), Machine Learning (ML), and the Internet of Things (IoT) in multi-omics creates significant opportunities for the market. This technology improves data integration, automation, and decision-making processes. AI and ML technologies analyze large volumes of complex data with the help of omics technologies and make accurate predictions with the help of charts and patterns. For instance, in March 2024, NVIDIA introduced NVIDIA Parabricks v4.3 integrated with AI techniques for multiple omics data types. NVIDIA Parabricks v4.3 analyzes multiple omics data types, including DNA, RNA, methylation, single-cell, and spatial omics workloads, using generative AI. Such integration of AI in the multi-omics field is expected to drive the market revenue during the forecast period.
Furthermore, the increasing adoption of cloud-based software transforms multi-omics data insights into advanced scientific discoveries. The market players such as Google, SCIEX OS, and PerkinElmer are considerably contributing to the market growth funding and new cloud-based product launches, to stay competitive in the market. For instance, in June 2023, Form Bio and Google Cloud partnered to provide multi-omics and precision medicine through the "Google Cloud Multi-omics Suite." Similarly, in May 2023, Google Cloud launched an AI-powered multi-omics suite for the interpretation of genomic data.
Single-cell omics technologies are widely used in cancer research. This technology can detect early-stage tumours, rare cancer cell populations, and circulating tumour cells in blood samples. Therefore, market players are consistently forming partnerships and launching new products to meet the demand for this technology. For instance, in June 2023, Honeycomb Biotechnologies & Revvity launched a new solution, HIVE CLX, for single-cell research. The HIVE CLX solution is designed to enable clinical researchers to overcome challenges in single-cell studies.
Multi-omics Market Report Highlights
Single-cell multi-omics segment accounted for the largest market share in 2023, owing to its use in developmental biology, & cancer biology for early disease diagnosis.
The metabolomics segment is expected to witness the highest growth during the forecast period, owing to technological advancement in metabolomics platforms.
Asia Pacific is projected to register the fastest growth over the study period, attributable to growing investments in cancer research enabling the use of multi-omics tools.
The global players include BD, Thermo Fisher Scientific, Illumina, Inc., Danaher (Beckman Coulter), Perkin Elmer, Shimadzu Corporation, and Bruker
Polaris Market Research has segmented the multi-omics market report based on product & service, type, platform, application, and region:
Multiomics, Product & Service Outlook (Revenue - USD million, 2019 - 2032)
- Products
- Instruments
- Consumables
- Software
- Services
Multiomics, Type Outlook (Revenue - USD million, 2019 - 2032)
- Single-cell Multi-omics
- Bulk Multi-omics
Multiomics, Platform Outlook (Revenue - USD million, 2019 - 2032)
- Genomics
- Transcriptomics
- Proteomics
- Metabolomics
- Integrated Omics Platforms
Multiomics, Application Outlook (Revenue - USD million, 2019 - 2032)
- Cell Biology
- Oncology
- Neurology
- Immunology
Multiomics, Regional Outlook (Revenue - USD million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Multiomics Market Insights
- 4.1. Multiomics Market - Market Snapshot
- 4.2. Multiomics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Technological Advancements in Single-Cell Multi-Omics
- 4.2.1.2. Increased Funding for Research and Development
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Investment in Advanced Type
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Multiomics Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Multiomics Market, by Product & Service
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 5.3. Products
- 5.3.1. Global Multiomics Market, by Products, by Region, 2019-2032 (USD Million)
- 5.3.2. Instruments
- 5.3.2.1. Global Multiomics Market, by Instruments, by Region, 2019-2032 (USD Million)
- 5.3.3. Consumables
- 5.3.3.1. Global Multiomics Market, by Consumables, by Region, 2019-2032 (USD Million)
- 5.3.4. Software Artillery Shells
- 5.3.4.1. Global Multiomics Market, by Software Artillery Shells, by Region, 2019-2032 (USD Million)
- 5.4. Services
- 5.4.1. Global Multiomics Market, by Services, by Region, 2019-2032 (USD Million)
6. Global Multiomics Market, by Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Multiomics Market, by Type, 2019-2032 (USD Million)
- 6.3. Single-cell Multi-omics
- 6.3.1. Global Multiomics Market, by Single-cell Multi-omics, by Region, 2019-2032 (USD Million)
- 6.4. Bulk Multi-omics
- 6.4.1. Global Multiomics Market, by Bulk Multi-omics, by Region, 2019-2032 (USD Million)
7. Global Multiomics Market, by Platform
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Multiomics Market, by Platform, 2019-2032 (USD Million)
- 7.3. Genomics
- 7.3.1. Global Multiomics Market, by Genomics, by Region, 2019-2032 (USD Million)
- 7.4. Transcriptomics
- 7.4.1. Global Multiomics Market, by Transcriptomics, by Region, 2019-2032 (USD Million)
- 7.5. Proteomics
- 7.5.1. Global Multiomics Market, by Proteomics, by Region, 2019-2032 (USD Million)
- 7.6. Metabolomics
- 7.6.1. Global Multiomics Market, by Metabolomics, by Region, 2019-2032 (USD Million)
- 7.7. Integrated Omics Platforms
- 7.7.1. Global Multiomics Market, by Other Integrated Omics Platforms, by Region, 2019-2032 (USD Million)
8. Global Multiomics Market, by Application
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Multiomics Market, by Application, 2019-2032 (USD Million)
- 8.3. Cell Biology
- 8.3.1. Global Multiomics Market, by Cell Biology, by Region, 2019-2032 (USD Million)
- 8.4. Oncology
- 8.4.1. Global Multiomics Market, by Oncology, by Region, 2019-2032 (USD Million)
- 8.5. Neurology
- 8.5.1. Global Multiomics Market, by Neurology, by Region, 2019-2032 (USD Million)
- 8.6. Immunology
- 8.6.1. Global Multiomics Market, by Immunology, by Region, 2019-2032 (USD Million)
9. Global Multiomics Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Multiomics Market Assessment, By Geography, 2019-2032 (USD Million)
- 9.3. Multiomics Market - North America
- 9.3.1. North America: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.3.2. North America: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.3.3. North America: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.3.4. North America: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.3.5. Multiomics Market - U.S.
- 9.3.5.1. U.S.: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.3.5.2. U.S.: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.3.5.3. U.S.: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.3.5.4. U.S.: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.3.6. Multiomics Market - Canada
- 9.3.6.1. Canada: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.3.6.2. Canada: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.3.6.3. Canada: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.3.6.4. Canada: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.4. Multiomics Market - Europe
- 9.4.1. Europe: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.4.2. Europe: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.4.3. Europe: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.4.4. Europe: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.4.5. Multiomics Market - UK
- 9.4.5.1. UK: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.4.5.2. UK: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.4.5.3. UK: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.4.5.4. UK: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.4.6. Multiomics Market - France
- 9.4.6.1. France: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.4.6.2. France: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.4.6.3. France: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.4.6.4. France: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.4.7. Multiomics Market - Germany
- 9.4.7.1. Germany: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.4.7.2. Germany: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.4.7.3. Germany: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.4.7.4. Germany: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.4.8. Multiomics Market - Italy
- 9.4.8.1. Italy: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.4.8.2. Italy: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.4.8.3. Italy: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.4.8.4. Italy: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.4.9. Multiomics Market - Spain
- 9.4.9.1. Spain: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.4.9.2. Spain: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.4.9.3. Spain: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.4.9.4. Spain: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.4.10. Multiomics Market - Netherlands
- 9.4.10.1. Netherlands: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.4.10.2. Netherlands: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.4.10.3. Netherlands: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.4.10.4. Netherlands: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.4.11. Multiomics Market - Russia
- 9.4.11.1. Russia: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.4.11.2. Russia: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.4.11.3. Russia: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.4.11.4. Russia: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.4.12. Multiomics Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.4.12.2. Rest of Europe: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.4.12.3. Rest of Europe: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.4.12.4. Rest of Europe: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.5. Multiomics Market - Asia Pacific
- 9.5.1. Asia Pacific: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.5.2. Asia Pacific: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.5.3. Asia Pacific: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.5.4. Asia Pacific: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.5.5. Multiomics Market - China
- 9.5.5.1. China: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.5.5.2. China: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.5.5.3. China: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.5.5.4. China: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.5.6. Multiomics Market - India
- 9.5.6.1. India: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.5.6.2. India: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.5.6.3. India: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.5.6.4. India: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.5.7. Multiomics Market - Malaysia
- 9.5.7.1. Malaysia: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.5.7.2. Malaysia: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.5.7.3. Malaysia: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.5.7.4. Malaysia: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.5.8. Multiomics Market - Japan
- 9.5.8.1. Japan: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.5.8.2. Japan: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.5.8.3. Japan: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.5.8.4. Japan: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.5.9. Multiomics Market - Indonesia
- 9.5.9.1. Indonesia: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.5.9.2. Indonesia: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.5.9.3. Indonesia: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.5.9.4. Indonesia: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.5.10. Multiomics Market - South Korea
- 9.5.10.1. South Korea: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.5.10.2. South Korea: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.5.10.3. South Korea: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.5.10.4. South Korea: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.5.11. Multiomics Market - Australia
- 9.5.11.1. Australia: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.5.11.2. Australia: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.5.11.3. Australia: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.5.11.4. Australia: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.5.12. Multiomics Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.5.12.2. Rest of Asia Pacific: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.5.12.3. Rest of Asia Pacific: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.5.12.4. Rest of Asia Pacific: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.6. Multiomics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.6.2. Middle East & Africa: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.6.3. Middle East & Africa: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.6.4. Middle East & Africa: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.6.5. Multiomics Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.6.5.2. Saudi Arabia: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.6.5.3. Saudi Arabia: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.6.5.4. Saudi Arabia: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.6.6. Multiomics Market - UAE
- 9.6.6.1. UAE: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.6.6.2. UAE: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.6.6.3. UAE: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.6.6.4. UAE: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.6.7. Multiomics Market - Israel
- 9.6.7.1. Israel: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.6.7.2. Israel: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.6.7.3. Israel: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.6.7.4. Israel: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.6.8. Multiomics Market - South Africa
- 9.6.8.1. South Africa: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.6.8.2. South Africa: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.6.8.3. South Africa: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.6.8.4. South Africa: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.6.9. Multiomics Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.6.9.2. Rest of Middle East & Africa: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.6.9.3. Rest of Middle East & Africa: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.6.9.4. Rest of Middle East & Africa: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.7. Multiomics Market - Latin America
- 9.7.1. Latin America: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.7.2. Latin America: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.7.3. Latin America: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.7.4. Latin America: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.7.5. Multiomics Market - Mexico
- 9.7.5.1. Mexico: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.7.5.2. Mexico: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.7.5.3. Mexico: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.7.5.4. Mexico: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.7.6. Multiomics Market - Brazil
- 9.7.6.1. Brazil: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.7.6.2. Brazil: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.7.6.3. Brazil: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.7.6.4. Brazil: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.7.7. Multiomics Market - Argentina
- 9.7.7.1. Argentina: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.7.7.2. Argentina: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.7.7.3. Argentina: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.7.7.4. Argentina: Multiomics Market, by Application, 2019-2032 (USD Million)
- 9.7.8. Multiomics Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
- 9.7.8.2. Rest of Latin America: Multiomics Market, by Type, 2019-2032 (USD Million)
- 9.7.8.3. Rest of Latin America: Multiomics Market, by Platform, 2019-2032 (USD Million)
- 9.7.8.4. Rest of Latin America: Multiomics Market, by Application, 2019-2032 (USD Million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. BD
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Thermo Fisher Scientific, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Illumina, Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Danaher (Beckman Coulter)
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. PerkinElmer, Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Shimadzu Corporation
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Bruker
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. QIAGEN
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Agilent Technologies, Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. BGI Genomics
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development